MMP3 and peripheral arterial disease: The lead variant at MMP3 (matrix metallopeptidase 3) remained associated with PAD but above the genome-wide significance threshold (odds ratio [OR; 95% CI], 1.07 [1.04–1.09], P=2.6×10−7).